News Detail
Beijing, 20 Sept 2024: China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster diabetes and obesity treatment, in a bid to curb a gray market that caters to growing demand for such therapies amid a global supp......
View Details
Source : Bloomberg
Asia
Pacific Rim
Business
China
Consumer Goods
Retail
Consumer Discretionary
Company News
Biotech & Pharma
Europe
General
Health Care
Industry
Internet
Legal
North America
Technology
Unites States
World
Related News
- PIL questioning quality of Anti-Rabies Vaccine disposed of by SC (22-01-2025)
- NCB seizes drugs worth more than 14 lakhs in Jaipur, One arrested (21-01-2025)
- Trump withdraws US from WHO (21-01-2025)
- Telangana Officials Raid Illegal De-Addiction Center in Hanumakonda (21-01-2025)
- Major pharmacy benefit managers found by US FTC to have inflated drug prices for a $7.3 billion gain (21-01-2025)
- Agra: Child given expired vaccine, doctor said- a mistake happened (21-01-2025)
- Police Seize Nearly 1,300 Bottles of Codeine Cough Syrup in Abandoned Vehicle (21-01-2025)
- Vaccine sector does not require incentives or breaks but needs relief from rigid price controls: Adar Poonawalla (21-01-2025)
- CSIR-IIIM Hosts Groundbreaking Workshop on Herbal Medicine Production (21-01-2025)
- 530 Sedative Pills seized from Nalagarh resident (21-01-2025)